Thonburi Healthcare Group, the country's third largest hospital operator, has inked an MoU with Korea’s Green Cross MS and Green Cross Laboratories.
Under the terms of the agreement, Green Cross will supply diagnostic reagents and will help to establish a clinical testing service network.
“We expect our company’s excellent diagnostic and testing technology and services will find sufficient customers in south east Asia,” said Lee Eun-hee, director of Green Cross Laboratories, while Kim Young-pil, CEO of Green Cross MS, said: “this MOU will likely serve as a bridgehead for the expansion of the market for diagnostic reagents and medical devices of Green Cross MS in the ASEAN market.”